Top 10 Healthcare Companies in the UK 2026

There are more healthcare companies in the UK today than just the NHS and a handful of private hospitals. There are pharmaceutical companies that operate on a global scale, insurers with tens of millions of customers, medical technology firms that sell in more than 100 countries, and digital health providers that care for patients at home.

These figures help explain how big the field has become. AstraZeneca made total revenue of $30.7 billion in the first half of 2026. GSK posted turnover of £16.0 billion over the same period. Bupa saw a 10% increase in revenue to £9.9 billion.

Long NHS waiting times have also led more people to take out private medical insurance, pay for treatment directly or use remote healthcare. That has opened space for providers such as Spire Healthcare and Nuffield Health, and for specialists such as Cera and Oviva.

So which names matter most right now? We looked at the companies that Google’s top results cover, then checked each one against its latest results and 2026 news. This guide looks at the top 10 healthcare companies in the UK for 2026, from FTSE 100 giants to the digital providers changing how care is delivered.

Why the UK’s Healthcare Companies Matter in 2026

They Anchor a Major Part of the Economy

Pharma, consumer health and medical technology account for some of the biggest listed companies in London. AstraZeneca, GSK and Haleon reported combined revenue of well over £50 billion in their last full financial years.

They Take Pressure Off the NHS

Private hospital groups treat patients funded by the NHS as well as insured and self-pay patients. Spire Healthcare made £495.5 million from the NHS in 2025, which is close to a third of its group revenue.

They Bring Care Into the Home

Digital and at-home care is now part of the mainstream. Cera says it delivers around 2.5 million home visits a month, while Oviva runs NHS-funded weight management programs entirely online.

They Drive Research and Jobs

Many of these companies spend heavily on research and development in the UK. GSK plans a new flagship R&D center at the Cambridge Biomedical Campus, where AstraZeneca already has its global headquarters.

Top 10 Healthcare Companies in the UK at a Glance

Rank	Company	Core segment	Key 2026 figure
1	AstraZeneca	Biopharmaceuticals	H1 2026 total revenue of $30.7bn, up 9%
2	GSK	Medicines and vaccines	H1 2026 turnover of £16.0bn
3	Bupa	Health insurance and care provision	H1 2026 revenue of £9.9bn, up 10%
4	Haleon	Consumer health	H1 2026 revenue of £5.6bn
5	Smith+Nephew	Medical technology	H1 2026 revenue of $3.1bn
6	Nuffield Health	Hospitals and wellbeing (charity)	FY25 revenue of £1.48bn
7	Spire Healthcare	Private hospitals	H1 2026 revenue of £792.7m
8	Hikma Pharmaceuticals	Generic and injectable medicines	H1 2026 revenue of $1.73bn, up 4%
9	Cera	Home healthcare	About 2.5m home visits a month
10	Oviva	Digital weight and diabetes care	$200m Series D raised in January 2026

Top 10 Healthcare Companies in the UK (2026)

Here’s our ranked list of the top 10 healthcare companies in the UK, based on scale, UK presence, recent performance and impact on patients.

1. AstraZeneca

AstraZeneca was created in 1999 when Sweden’s Astra AB merged with the UK’s Zeneca Group. It has its headquarters on the Cambridge Biomedical Campus and had approximately 89,900 employees in 2025. Under CEO Sir Pascal Soriot, it’s the largest of the top 10 healthcare companies in the UK by revenue, with total revenue of $58.7 billion in 2025, an increase of 8%.

Growth continued in 2026. AstraZeneca made total revenue of $30.7 billion in the first half, up 9% on a reported basis, with both oncology and rare disease growing at double-digit rates. The company has reported 30 approvals in major regions since its Q4 2025 results, including US approval of Baxfendy for hypertension. Its ordinary shares also started trading on the New York Stock Exchange on February 2, 2026.

Key Healthcare Solutions
✔ Oncology medicines such as Imfinzi, Enhertu and Calquence
✔ Rare disease treatments including Ultomiris
✔ Cardiovascular, renal and metabolic medicines such as Farxiga
✔ Respiratory and immunology therapies such as Fasenra

Best for: Hospitals, health systems and partners seeking innovative specialty medicines.

2. GSK

GSK is a London-headquartered biopharma company specializing in vaccines, specialty medicines and general medicines. It moved its global headquarters back to central London, on New Oxford Street. GSK reported turnover of £32.7 billion in 2025, up 4% at actual exchange rates and 7% at constant rates.

Under CEO Luke Miels, GSK posted turnover of £16.0 billion in the first half of 2026. In the second quarter, specialty medicines sales grew 14% to £3.8 billion, driven mainly by HIV medicines such as Dovato and Cabenuva, while vaccine sales rose 9%. GSK has launched an “Accelerate Growth” program targeting £1.9 billion in annual savings by 2029 and expects more than 20 phase III trial starts in 2026.

Key Healthcare Solutions
✔ Vaccines including Shingrix, Arexvy and meningitis vaccines
✔ HIV medicines through ViiV Healthcare, such as Dovato and Apretude
✔ Respiratory and immunology medicines such as Trelegy
✔ Oncology treatments in development and on the market

Best for: Health systems looking for vaccines and long-acting infectious disease treatments.

3. Bupa

Bupa was founded in 1947, when 17 British provident associations joined forces to provide healthcare to the public. It’s based in central London and is a company limited by guarantee, meaning it has no shareholders and its profits are reinvested in the business. Bupa’s revenue rose 7% to £18.15 billion in 2025, and its workforce reached 103,849.

Bupa kept up its momentum in 2026. First-half revenue grew 10% to £9.9 billion, underlying profit rose 24% to £594 million, and insurance customers increased 12% to 49.7 million worldwide. In the UK, insurance revenue reached £3.54 billion in 2025, and the group has signed a four-year strategic partnership with Spire Healthcare. CEO Iñaki Ereño leads the group.

Key Healthcare Solutions
✔ Private medical insurance for individuals and businesses
✔ International private medical insurance
✔ Health clinics, dental care and care homes
✔ Health provision for more than 15 million customers

Best for: Employers and individuals who want private health cover with a large care network.

4. Haleon

Haleon is the consumer health company spun off from GSK on July 18, 2022. It’s based in Weybridge, Surrey, and is led by CEO Brian McNamara. It owns some of the world’s best-known over-the-counter brands and reported revenue of £11.03 billion in 2025.

Haleon’s revenue rose 2.2% to £5.6 billion in the first half of 2026, with organic growth of 2.6%. The company reaffirmed its full-year guidance of 3-5% organic revenue growth and high single-digit growth in adjusted operating profit at constant currency. Its medium-term target is 4-6% organic revenue growth a year, along with further gross margin expansion.

Key Healthcare Solutions
✔ Oral health brands such as Sensodyne and Aquafresh
✔ Pain relief including Panadol, Advil and Voltaren
✔ Vitamins and supplements such as Centrum
✔ Smoking cessation and digestive health products like Nicorette and Tums

Best for: Retailers, pharmacies and consumers looking for trusted everyday health products.

5. Smith+Nephew

Smith+Nephew was established in 1856 by Thomas James Smith. Today it’s a medical technology company based in Watford, England, with around 18,000 employees and products sold in more than 100 countries. It reported revenue of $6.16 billion in 2025.

In the first half of 2026, Smith+Nephew made revenue of $3.10 billion, up 4.6% on a reported basis and 2.3% on an underlying basis. It lowered its full-year underlying revenue growth forecast to about 4%, but still expects trading profit to grow by about 8% excluding acquisitions and free cash flow of around $800 million. CEO Deepak Nath leads the company’s three business units.

Key Healthcare Solutions
✔ Orthopedics, including hip and knee implant systems
✔ Sports medicine and ENT, including REGENETEN and CARTIHEAL AGILI-C
✔ Advanced wound management, including PICO and ALLEVYN
✔ Wound bioactives such as SANTYL

Best for: Hospitals and surgeons needing orthopedic, sports medicine and wound care technology.

6. Nuffield Health

Founded in 1957, Nuffield Health is headquartered in Epsom, Surrey. It’s a registered charity and not-for-profit organization that operates independently of the NHS, providing a mix of hospitals and fitness and wellbeing services. Revenue was £1.48 billion for FY25, an increase of 2.2%.

According to LaingBuisson, Nuffield Health posted record profits for FY25 as its cost-cutting and efficiency measures began to take effect. The group runs 35 hospitals as well as a gym and corporate fitness portfolio of more than 200 sites. That lets it offer many kinds of care under one brand, from surgery and diagnostics to physiotherapy and health assessments. CEO Alex Perry has led the organization since 2024.

Key Healthcare Solutions
✔ Private hospital treatment and surgery
✔ Health assessments and diagnostics
✔ Physiotherapy and musculoskeletal care
✔ Fitness and wellbeing centers and corporate wellbeing programs

Best for: People and employers who want treatment and prevention from one not-for-profit provider.

7. Spire Healthcare

Spire Healthcare was created in 2007, when it bought Bupa’s UK hospitals business. Based in London, it operates 38 hospitals and more than 60 clinics, medical centers and consulting rooms throughout England, Wales and Scotland. It treated over one million patients in 2025 and posted revenue of £1.58 billion, a rise of 4.5%.

2026 has brought plenty of change. First-half revenue was broadly flat at £792.7 million as NHS revenue fell 14%. The board has recommended a £1.03 billion takeover offer from Tulip UK Bidco, which is backed by Toscafund, THCP and Ares. David Sloman became interim CEO after Justin Ash retired. Spire also became Team GB’s exclusive healthcare partner through 2028 and signed a four-year partnership with Bupa.

Key Healthcare Solutions
✔ Private inpatient, outpatient and day-case treatment
✔ NHS-funded procedures to help reduce waiting lists
✔ Orthopedics, cancer care and diagnostics
✔ Self-pay and insured treatment packages

Best for: Insured and self-pay patients who want faster access to hospital treatment.

8. Hikma Pharmaceuticals

Hikma Pharmaceuticals was founded in 1978 in Amman, Jordan, by Samih Darwazah and is now based in London. It listed on the London Stock Exchange in 2005 and employs about 9,500 people. As a global company with its head office in the UK, it makes generic, injectable and branded medicines.

Hikma’s revenue rose 4% to $1.73 billion in the first half of 2026, and core operating profit climbed 9% to $405 million. The Branded business grew revenue 15% to $502 million, while Injectables held steady at $685 million. Full-year guidance remains 2-4% revenue growth at constant currency and core operating profit of $720 million to $770 million.

Key Healthcare Solutions
✔ Injectable medicines for hospitals
✔ Generic prescription medicines through Hikma Rx
✔ Branded medicines through its Branded business

Best for: Hospitals and pharmacies that need reliable, affordable generic and injectable medicines.

9. Cera

Cera launched in 2016 and is run by founder and CEO Dr Ben Maruthappu. It’s a London-based home healthcare provider that uses technology to help nurses and carers look after people in their own homes. Cera says it makes around 2.5 million home visits a month, about one every second, with a team of more than 10,000 carers and nurses.

Cera reported annualized revenue of about $500 million, up from $5 million at the start of 2020. It works with more than 150 UK local governments and two-thirds of NHS Integrated Care Systems, runs almost 150 regulated sites and also operates in Germany. The company says its technology can predict risks such as falls and infections seven days in advance and cut patient falls by 20%.

Key Healthcare Solutions
✔ Home care and live-in care
✔ Home nursing and hospital discharge support
✔ Predictive risk alerts for falls and infections
✔ Digital care planning for councils and the NHS

Best for: Councils, NHS partners and families who need dependable care at home.

10. Oviva

Oviva was founded in 2014 by Kai Eberhardt and Manuel Baumann and runs digital programs for weight management, diabetes and other diet-related conditions. The UK is one of its three core markets, along with Germany and Switzerland. Oviva has supported more than one million patients, including over 300,000 NHS patients.

In January 2026, Oviva raised $200 million in a Series D round led by Kinnevik, which invested $100 million. Its NHS-funded Tier 3 weight management program helps adults with complex obesity entirely remotely, combining diet, exercise and psychological support, with GLP-1 medication for suitable patients. The program is led by a consultant endocrinologist and regulated by the CQC.

Key Healthcare Solutions
✔ NHS-funded remote weight management programs
✔ Type 2 diabetes and diet-related care
✔ GLP-1 medication support with clinical oversight
✔ App-based progress tracking and coaching

Best for: NHS commissioners and patients who want specialist weight care without travel.

Also read: Top 10 Pharmaceutical Companies in USA | Health Insurance Companies in USA

How to Choose the Right Healthcare Partner

Match the Company to the Need

The top 10 healthcare companies in the UK don’t all do the same job. Drug makers, insurers and home care providers solve very different problems, so start with what you actually need, whether that’s medicines, cover for staff, hospital treatment or care at home.

Check Regulation and Quality

All UK care providers should be registered with the Care Quality Commission or the equivalent body in Scotland, Wales or Northern Ireland. Always read recent inspection reports before you sign anything.

Look at NHS Links

Many private and digital providers also deliver NHS-funded services. Strong NHS links can be a sign of proven results and solid clinical governance.

Review Financial Strength

Results, ownership changes and takeover bids can all affect a provider. Check the latest annual or half-year results, especially before entering a long-term contract.

Ask About Access and Speed

As a patient, waiting times and locations matter most. Ask how soon you can be seen, where you’ll be treated and whether remote care is available.

Frequently Asked Questions About Healthcare Companies in the UK

What is the largest healthcare company in the UK?

AstraZeneca has the highest revenue, at $58.7 billion in 2025, followed by GSK with turnover of £32.7 billion. Among care providers, Bupa is the largest, with revenue of £18.15 billion in 2025.

Which are the biggest private hospital groups in the UK?

Spire Healthcare and Nuffield Health are two of the largest, with 38 and 35 hospitals respectively. Other major operators include Circle Health Group and HCA Healthcare UK.

Are digital health companies part of the top 10 healthcare companies in the UK?

Yes. Cera and Oviva made our list because of their scale and NHS work. They’re much smaller than the big drug makers, but they’re changing how many patients receive care.

Which company is best for me?

There’s no single best choice for everyone. An employer may want to compare insurers such as Bupa, while a patient waiting for surgery might look at Spire or Nuffield Health. Choose based on your needs, budget and location.

Conclusion

The top 10 healthcare companies in the UK cover the whole system, from drug makers such as AstraZeneca and GSK to insurers like Bupa and home care providers such as Cera. Most have grown in 2026, though some, like Spire, have had a tougher year.

Whether you’re an investor, an employer or a patient, the top 10 healthcare companies in the UK are worth knowing. Use this list as a starting point, then check each provider’s latest results and services against what you need.